Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
RG-6524 by F. Hoffmann-La Roche for Small-Cell Lung Cancer: Likelihood of Approval
RG-6524 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Small-Cell Lung Cancer. According to...
Data Insights
RG-6524 by F. Hoffmann-La Roche for Solid Tumor: Likelihood of Approval
RG-6524 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Solid Tumor. According to GlobalData,...